Get the Daily Brief
Latest Biotech News
Lila Sciences Raises $235 Million to Build AI-Powered Autonomous Research Labs
Flagship Pioneering-backed Lila Sciences secured a $235 million Series A funding round to develop fully autonomous labs integrating artificial intelligence into biological research workflows....
Eli Lilly Selects Virginia for $5 Billion API Manufacturing Site with ADC Focus
Eli Lilly announced the selection of Goochland County, Virginia, as the site for a new $5 billion active pharmaceutical ingredient (API) manufacturing facility, the first dedicated fully...
Breakthrough AI Algorithm Uses Mammograms to Predict Cardiovascular Risk in Women
The George Institute for Global Health researchers developed a machine learning model that analyzes routine mammographic images to accurately predict women's cardiovascular disease risk. This...
FDA Cracks Down on Pharma Ads – Letters Target Misleading Drug Promotions
The FDA released approximately 100 warning letters to pharmaceutical companies and telehealth providers, including Novartis and Eli Lilly, demanding changes to drug advertisements deemed...
Personalized Ovarian Cancer Risk Score Unveiled – Queen Mary University Advances Early Detection
Researchers at Queen Mary University of London introduced Ovatools, a personalized diagnostic instrument combining biochemical markers with demographic data for improved ovarian cancer risk...
Human Proteoform Atlas Aims to Advance Precision Medicine – Mapping Protein Variants
A collaborative effort seeks to comprehensively map the myriad proteoforms—the distinct molecular forms of proteins produced from a single gene—across human tissues. This project aims to establish...
Advanced Biomanufacturing: CDMO Market Expands Amid Rising Biologic Demand
A Jefferies report highlights robust growth in contract development and manufacturing organizations (CDMOs), fuelled primarily by rising demand for biologics including monoclonal antibodies and...
Lilly Picks Virginia for $5 Billion Bioconjugate Manufacturing Hub
Eli Lilly has selected a site near Richmond, Virginia, for its first fully integrated active pharmaceutical ingredient (API) and drug product facility dedicated to bioconjugates including...
Novartis Expands Collaboration with Monte Rosa in Molecular Glue Drug Development
Novartis has entered a new partnership with Monte Rosa Therapeutics, securing an exclusive license to a novel molecular glue degrader drug candidate and options on two additional preclinical...
FDA Approves Biocartis Colorectal Cancer Companion Diagnostic Test
Biocartis has achieved FDA premarket approval for its Idylla Cdx MSI Test, designed to identify colorectal cancer patients with microsatellite instability-high (MSI-H) tumors who may benefit from...
New AI Algorithm Predicts Cardiovascular Risk Using Mammograms
Researchers at The George Institute for Global Health have developed an artificial intelligence model that accurately predicts cardiovascular disease risk in women by analyzing standard mammogram...
aTyr Pharma’s Efzofitimod Falls Short in Phase 3 Pulmonary Sarcoidosis Trial
Biotech company aTyr Pharma announced that its lead candidate efzofitimod did not meet the primary endpoint in a Phase 3 study evaluating steroid tapering efficacy in patients with pulmonary...
Breakthrough in Neuroscience Maps Brain Circuits Driving Visual Illusions
A collaborative study between University of California, Berkeley and the Allen Institute has identified a subset of neurons in the primary visual cortex that specifically encode illusory...
Mount Sinai Unveils NIH-Funded Virtual Cancer Center and AI-Powered Research Lab
Mount Sinai Comprehensive Cancer Center received a $1.7 million Department of Defense grant to support the Convergent Science Virtual Cancer Center, aiming to innovate oncology research and...
Lila Sciences Raises $235 Million to Build AI-Powered Autonomous Research Labs
Flagship Pioneering-backed startup Lila Sciences announced a $235 million Series A funding round to accelerate the development of AI-driven autonomous laboratories aimed at transforming drug...
GLP-1 Weight-Loss Drugs Face Regulatory and Market Scrutiny Amid Influential Direct-To-Consumer Advertising
GLP-1-based weight-loss medications, promoted both by pharma companies with careful regulatory compliance and by telehealth providers through direct-to-consumer campaigns, face contrasting...
FDA Approves Biocartis-BMS MSI Test for Colorectal Cancer Precision
Biocartis has secured FDA premarket approval for its Idylla CDx MSI test, developed in partnership with Bristol Myers Squibb. This automated, cartridge-based test rapidly identifies microsatellite...
Novartis and Monte Rosa Expand $5.7B Molecular Glue Immune Drug Partnership
Novartis has broadened its collaboration with Monte Rosa Therapeutics by licensing an exclusive molecular glue degrader targeting an undisclosed protein for immune-mediated diseases. The deal...
aTyr Pharma’s Efzofitimod Fails Phase III Pulmonary Sarcoidosis Trial
aTyr Pharma’s lead drug candidate efzofitimod missed the primary endpoint in a pivotal phase III trial aiming to reduce oral corticosteroid use in patients with pulmonary sarcoidosis. While the...
China Adds Three Biotech Firms to U.S. Export Control Entity List
The U.S. Department of Commerce’s Bureau of Industry and Security updated the Export Administration Regulations to designate 32 new entities including three Chinese biotechnology companies—Beijing...